|
2025-03-20 |
2025-03-19 |
S
Sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
3,333
-5.2%
8.27
USD 27,564
|
3,333
-5.2%
|
8.27
|
USD 27,564
|
|
|
2025-03-20 |
2025-03-19 |
S
Sale
|
Kaye Edward M. MD
Non-Executive Director
|
8,907
-6.0%
8.27
USD 73,661
|
8,907
-6.0%
|
8.27
|
USD 73,661
|
|
|
2025-03-20 |
2025-03-19 |
S
Sale
|
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Officer
|
1,945
-5.8%
8.27
USD 16,085
|
1,945
-5.8%
|
8.27
|
USD 16,085
|
|
|
2025-03-20 |
2025-03-18 |
S
Sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
3,884
-5.7%
8.67
USD 33,674
|
3,884
-5.7%
|
8.67
|
USD 33,674
|
|
|
2025-03-20 |
2025-03-18 |
S
Sale
|
Kaye Edward M. MD
Non-Executive Director
|
10,382
-6.5%
8.67
USD 90,012
|
10,382
-6.5%
|
8.67
|
USD 90,012
|
|
|
2025-03-20 |
2025-03-18 |
S
Sale
|
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Officer
|
2,266
-6.3%
8.67
USD 19,646
|
2,266
-6.3%
|
8.67
|
USD 19,646
|
|
|
2024-12-27 |
2024-12-23 |
S
Sale
|
Skorpios Trust
Large shareholder
|
2,000,000
-22.5%
11.50
USD 23,000,000
|
2,000,000
-22.5%
|
11.50
|
USD 23,000,000
|
|
|
2024-12-11 |
2024-12-09 |
S
Sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
2,586
-5.5%
12.99
USD 33,596
|
2,586
-5.5%
|
12.99
|
USD 33,596
|
|
|
2024-12-11 |
2024-12-09 |
S
Sale
|
Kaye Edward M. MD
CEO
Executive Director
|
6,786
-9.9%
12.99
USD 88,158
|
6,786
-9.9%
|
12.99
|
USD 88,158
|
|
|
2024-12-11 |
2024-12-09 |
S
Sale
|
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Officer
|
1,552
-6.7%
12.99
USD 20,164
|
1,552
-6.7%
|
12.99
|
USD 20,164
|
|
|
2024-12-11 |
2024-12-09 |
PS
Planned sale
|
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Officer
|
12,114
-34.5%
13.69
USD 165,814
|
12,114
-34.5%
|
13.69
|
USD 165,814
|
|
|
2024-12-10 |
2024-12-06 |
S
Sale
|
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Officer
|
9,696
-21.6%
12.78
USD 123,891
|
9,696
-21.6%
|
12.78
|
USD 123,891
|
|
|
2024-12-10 |
2024-12-06 |
S
Sale
|
Kaye Edward M. MD
CEO
Executive Director
|
6,170
-8.2%
12.78
USD 78,837
|
6,170
-8.2%
|
12.78
|
USD 78,837
|
|
|
2024-12-10 |
2024-12-06 |
S
Sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
13,945
-22.8%
12.78
USD 178,182
|
13,945
-22.8%
|
12.78
|
USD 178,182
|
|
|
2024-12-03 |
2024-12-02 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
10,000
-16.3%
12.07
USD 120,698
|
10,000
-16.3%
|
12.07
|
USD 120,698
|
|
|
2024-11-05 |
2024-11-01 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
10,000
-80.1%
12.68
USD 126,803
|
10,000
-80.1%
|
12.68
|
USD 126,803
|
|
|
2024-10-02 |
2024-10-01 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
10,000
-80.1%
12.06
USD 120,648
|
10,000
-80.1%
|
12.06
|
USD 120,648
|
|
|
2024-09-23 |
2024-09-19 |
S
Sale
|
Skorpios Trust
Large shareholder
|
1,937,500
-17.9%
14.05
USD 27,221,875
|
1,937,500
-17.9%
|
14.05
|
USD 27,221,875
|
|
|
2024-09-05 |
2024-09-03 |
S
Sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
600
-19.4%
15.41
USD 9,245
|
600
-19.4%
|
15.41
|
USD 9,245
|
|
|
2024-09-05 |
2024-09-03 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
9,400
-75.3%
14.92
USD 140,236
|
9,400
-75.3%
|
14.92
|
USD 140,236
|
|
|
2024-08-05 |
2024-08-01 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
10,000
-80.1%
14.58
USD 145,843
|
10,000
-80.1%
|
14.58
|
USD 145,843
|
|
|
2024-07-03 |
2024-07-02 |
PS
Planned sale
|
Nash Huw M.
Chief Business Officer
Officer
|
33
-100.0%
13.90
USD 459
|
33
-100.0%
|
13.90
|
USD 459
|
|
|
2024-07-03 |
2024-07-02 |
PS
Planned sale
|
Nash Huw M.
Chief Business Officer
Officer
|
2,467
-98.7%
13.10
USD 32,320
|
2,467
-98.7%
|
13.10
|
USD 32,320
|
|
|
2024-07-03 |
2024-07-01 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
10,000
-80.1%
13.75
USD 137,458
|
10,000
-80.1%
|
13.75
|
USD 137,458
|
|
|
2024-06-05 |
2024-06-03 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
103
-4.0%
15.78
USD 1,625
|
103
-4.0%
|
15.78
|
USD 1,625
|
|
|
2024-06-05 |
2024-06-03 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
9,897
-79.3%
15.21
USD 150,560
|
9,897
-79.3%
|
15.21
|
USD 150,560
|
|
|
2024-05-22 |
2024-05-20 |
PS
Planned sale
|
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Officer
|
8,599
-76.8%
15.04
USD 129,327
|
8,599
-76.8%
|
15.04
|
USD 129,327
|
|
|
2024-05-22 |
2024-05-20 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
50,000
-100.0%
15.39
USD 769,500
|
50,000
-100.0%
|
15.39
|
USD 769,500
|
|
|
2024-05-22 |
2024-05-20 |
PS
Planned sale
|
Kaye Edward M. MD
CEO
Executive Director
|
2,664
-9.0%
16.05
USD 42,746
|
2,664
-9.0%
|
16.05
|
USD 42,746
|
|
|
2024-05-22 |
2024-05-20 |
PS
Planned sale
|
Kaye Edward M. MD
CEO
Executive Director
|
2,664
-9.0%
16.05
USD 42,746
|
2,664
-9.0%
|
16.05
|
USD 42,746
|
|
|
2024-05-22 |
2024-05-20 |
PS
Planned sale
|
Kaye Edward M. MD
CEO
Executive Director
|
39,686
-57.2%
15.39
USD 610,783
|
39,686
-57.2%
|
15.39
|
USD 610,783
|
|
|
2024-05-22 |
2024-05-20 |
PS
Planned sale
|
Kaye Edward M. MD
CEO
Executive Director
|
39,686
-57.2%
15.39
USD 610,783
|
39,686
-57.2%
|
15.39
|
USD 610,783
|
|
|
2024-05-03 |
2024-05-01 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
10,000
-80.1%
11.37
USD 113,653
|
10,000
-80.1%
|
11.37
|
USD 113,653
|
|
|
2024-04-18 |
2024-04-17 |
S
Sale
|
Skorpios Trust
Large shareholder
|
3,600,000
-24.9%
11.60
USD 41,760,000
|
3,600,000
-24.9%
|
11.60
|
USD 41,760,000
|
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
400
-100.0%
13.61
USD 5,444
|
400
-100.0%
|
13.61
|
USD 5,444
|
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
60,929
-99.3%
13.22
USD 805,768
|
60,929
-99.3%
|
13.22
|
USD 805,768
|
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
9,426
-79.1%
13.23
USD 124,684
|
9,426
-79.1%
|
13.23
|
USD 124,684
|
|
|
2024-04-01 |
2024-03-28 |
PS
Planned sale
|
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Officer
|
100
-3.7%
13.81
USD 1,381
|
100
-3.7%
|
13.81
|
USD 1,381
|
|
|
2024-04-01 |
2024-03-28 |
PS
Planned sale
|
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Officer
|
5,026
-65.1%
13.19
USD 66,287
|
5,026
-65.1%
|
13.19
|
USD 66,287
|
|
|
2024-03-19 |
2024-03-19 |
S
Sale
|
Nash Huw M.
COO & CBO
Officer
|
4,116
-26.6%
6.10
USD 25,102
|
4,116
-26.6%
|
6.10
|
USD 25,102
|
|
|
2024-03-19 |
2024-03-19 |
S
Sale
|
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Officer
|
2,349
-23.3%
6.10
USD 14,326
|
2,349
-23.3%
|
6.10
|
USD 14,326
|
|
|
2024-03-19 |
2024-03-19 |
S
Sale
|
Tulipano Stephen J
CFO
Officer
|
4,116
-16.6%
6.10
USD 25,102
|
4,116
-16.6%
|
6.10
|
USD 25,102
|
|
|
2024-03-19 |
2024-03-19 |
S
Sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
4,116
-26.4%
6.10
USD 25,102
|
4,116
-26.4%
|
6.10
|
USD 25,102
|
|
|
2024-03-19 |
2024-03-19 |
S
Sale
|
Kaye Edward M. MD
CEO
Executive Director
|
11,150
-13.9%
6.10
USD 67,999
|
11,150
-13.9%
|
6.10
|
USD 67,999
|
|
|
2024-03-05 |
2024-03-01 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
10,000
-80.1%
7.75
USD 77,469
|
10,000
-80.1%
|
7.75
|
USD 77,469
|
|
|
2024-02-05 |
2024-02-01 |
PS
Planned sale
|
Ticho Barry
CHIEF MEDICAL OFFICER
Officer
|
10,000
-58.9%
4.80
USD 47,991
|
10,000
-58.9%
|
4.80
|
USD 47,991
|
|
|
2024-01-04 |
2024-01-02 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
10,000
-37.1%
5.74
USD 57,352
|
10,000
-37.1%
|
5.74
|
USD 57,352
|
|
|
2023-07-06 |
2023-07-03 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
15,000
-36.7%
10.60
USD 158,973
|
15,000
-36.7%
|
10.60
|
USD 158,973
|
|
|
2023-06-23 |
2023-06-21 |
PS
Planned sale
|
Allan Jonathan
General Counsel & Corp Sec
Officer
|
1,948
-100.0%
13.48
USD 26,252
|
1,948
-100.0%
|
13.48
|
USD 26,252
|
|
|
2023-06-05 |
2023-06-01 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
15,000
-26.8%
11.13
USD 166,964
|
15,000
-26.8%
|
11.13
|
USD 166,964
|
|
|
2023-05-08 |
2023-05-04 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
653
-1.2%
10.00
USD 6,530
|
653
-1.2%
|
10.00
|
USD 6,530
|
|
|
2023-05-03 |
2023-05-03 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
24,697
-30.4%
10.14
USD 250,366
|
24,697
-30.4%
|
10.14
|
USD 250,366
|
|
|
2023-05-03 |
2023-05-02 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
5,513
-6.4%
10.00
USD 55,134
|
5,513
-6.4%
|
10.00
|
USD 55,134
|
|
|
2023-05-03 |
2023-05-01 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
24,967
-22.3%
10.00
USD 249,767
|
24,967
-22.3%
|
10.00
|
USD 249,767
|
|
|
2023-02-07 |
2023-02-06 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
9,235
-7.6%
10.02
USD 92,491
|
9,235
-7.6%
|
10.02
|
USD 92,491
|
|
|
2023-02-07 |
2023-02-03 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
3,763
-3.0%
10.03
USD 37,745
|
3,763
-3.0%
|
10.03
|
USD 37,745
|
|
|
2023-02-02 |
2023-02-02 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
267
-0.2%
10.00
USD 2,670
|
267
-0.2%
|
10.00
|
USD 2,670
|
|
|
2023-02-02 |
2023-02-01 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
5,705
-4.4%
10.02
USD 57,140
|
5,705
-4.4%
|
10.02
|
USD 57,140
|
|
|
2023-02-02 |
2023-01-31 |
PS
Planned sale
|
Ticho Barry
Chief Medical Officer
Officer
|
200
-0.2%
10.00
USD 2,000
|
200
-0.2%
|
10.00
|
USD 2,000
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
200
-100.0%
24.07
USD 4,814
|
200
-100.0%
|
24.07
|
USD 4,814
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
2,103
-91.3%
23.40
USD 49,219
|
2,103
-91.3%
|
23.40
|
USD 49,219
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
1,497
-39.4%
22.47
USD 33,633
|
1,497
-39.4%
|
22.47
|
USD 33,633
|
|
|
2021-12-03 |
2021-12-01 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
2,500
-100.0%
25.06
USD 62,656
|
2,500
-100.0%
|
25.06
|
USD 62,656
|
|
|
2021-12-03 |
2021-12-01 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
3,200
-56.1%
23.96
USD 76,674
|
3,200
-56.1%
|
23.96
|
USD 76,674
|
|
|
2021-11-03 |
2021-11-03 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
1,900
-100.0%
25.00
USD 47,500
|
1,900
-100.0%
|
25.00
|
USD 47,500
|
|
|
2021-11-03 |
2021-11-01 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
1,610
-100.0%
23.72
USD 38,195
|
1,610
-100.0%
|
23.72
|
USD 38,195
|
|
|
2021-11-03 |
2021-11-01 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
2,190
-57.6%
23.41
USD 51,261
|
2,190
-57.6%
|
23.41
|
USD 51,261
|
|
|
2021-10-04 |
2021-10-01 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
5,700
-100.0%
24.83
USD 141,506
|
5,700
-100.0%
|
24.83
|
USD 141,506
|
|
|
2021-06-03 |
2021-06-01 |
PS
Planned sale
|
Nash Huw M.
COO & CBO
Officer
|
575
-100.0%
39.43
USD 22,669
|
575
-100.0%
|
39.43
|
USD 22,669
|
|
|
2021-03-04 |
2021-03-02 |
PS
Planned sale
|
Liau Gene
EVP Research & Preclinical Dev
Officer
|
2,900
-12.0%
63.52
USD 184,195
|
2,900
-12.0%
|
63.52
|
USD 184,195
|
|
|
2021-03-04 |
2021-03-02 |
PS
Planned sale
|
Liau Gene
EVP Research & Preclinical Dev
Officer
|
2,295
-8.6%
62.46
USD 143,351
|
2,295
-8.6%
|
62.46
|
USD 143,351
|
|
|
2021-03-03 |
2021-03-01 |
PS
Planned sale
|
LEVIN ARTHUR A
Non-Executive Director
|
4,957
-100.0%
61.14
USD 303,087
|
4,957
-100.0%
|
61.14
|
USD 303,087
|
|
|
2021-03-03 |
2021-03-01 |
PS
Planned sale
|
LEVIN ARTHUR A
Non-Executive Director
|
7,543
-60.3%
60.55
USD 456,754
|
7,543
-60.3%
|
60.55
|
USD 456,754
|
|
|
2021-02-24 |
2021-02-23 |
PS
Planned sale
|
Tulipano Stephen J
CFO
Officer
|
5,000
-89.3%
58.60
USD 292,992
|
5,000
-89.3%
|
58.60
|
USD 292,992
|
|
|
2021-02-24 |
2021-02-22 |
PS
Planned sale
|
Tulipano Stephen J
CFO
Officer
|
102
-14.5%
60.00
USD 6,120
|
102
-14.5%
|
60.00
|
USD 6,120
|
|
